Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds specifically to the CD20 antigen expressed on pre-B...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda-Hernández, Mariana P., López-Morales, Carlos A., Ramírez-Ibáñez, Nancy D., Piña-Lara, Nelly, Pérez, Nestor O., Molina-Pérez, Aarón, Revilla-Beltri, Jorge, Flores-Ortiz, Luis F., Medina-Rivero, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418000/
https://www.ncbi.nlm.nih.gov/pubmed/25973441
http://dx.doi.org/10.1155/2015/910763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418000/
https://www.ncbi.nlm.nih.gov/pubmed/25973441
http://dx.doi.org/10.1155/2015/910763

Ejemplares similares